• No results found

Nonfunctioning pituitary macroadenomas : treatment and long-term follow-up

N/A
N/A
Protected

Academic year: 2021

Share "Nonfunctioning pituitary macroadenomas : treatment and long-term follow-up"

Copied!
17
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)Nonfunctioning pituitary macroadenomas : treatment and long-term follow-up Dekkers, Olaf Matthijs. Citation Dekkers, O. M. (2006, November 8). Nonfunctioning pituitary macroadenomas : treatment and long-term follow-up. Retrieved from https://hdl.handle.net/1887/4975 Version:. Corrected Publisher’s Version. License:. Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded from:. https://hdl.handle.net/1887/4975. Note: To cite this publication please use the final published version (if applicable)..

(2) 1UALITYOFLIFEISDECREASEDINPATIENTS TREATEDFORNONFUNCTIONINGPITUITARY MACROADENOMA. /-$EKKERS

(3) !!VANDER+LAAUW

(4) !-0EREIRA

(5) .2"IERMASZ

(6) 0*(ONKOOP

(7) &2OELFSEMA

(8) *7!3MIT

(9) *!2OMIJN $EPARTMENTOF%NDOCRINOLOGYAND-ETABOLIC$ISEASES

(10) ,EIDEN5NIVERSITY-EDICAL #ENTER

(11) ,EIDEN

(12) 4HE.ETHERLANDS *OURNALOF#LINICAL%NDOCRINOLOGYAND-ETABOLISM3EP  . $)"15&3.

(13) 46.."3: /BJECTIVE!LTHOUGHAREDUCEDQUALITYOFLIFE1O, HASBEENREPORTEDAFTERLONG TERMCURE OFFUNCTIONINGPITUITARYADENOMAS

(14) THEEFFECTOFSUCCESSFULTREATMENTOFNONFUNCTIONING PITUITARY MACROADENOMA .&-! ON 1O, HAS NOT BEEN FULLY ADDRESSED 4HEREFORE

(15) WE EVALUATEDABROADSPECTRUMOF1O,PARAMETERSINPATIENTSSUCCESSFULLYTREATEDFOR.&-! INOURCENTER $ESIGN#ASE CONTROLSTUDY 0ATIENTS AND -ETHODS 7E ASSESSED 1O, IN  ADULT PATIENTS MEAN AGE 

(16) RANGE  YR

(17) INREMISSIONDURINGLONG TERMFOLLOWUPAFTERSURGICALN ANDADDITIONAL RADIOTHERAPEUTIC N TREATMENT FOR .&-! BY FOUR VALIDATED HEALTH RELATED QUESTION NAIRES(!$3

(18) -&) 

(19) .(0

(20) 3&  0ATIENTOUTCOMESWERECOMPAREDWITHCONTROLS ANDWITHAGE ADJUSTEDREFERENCEVALUESDERIVEDFROMLITERATURE 2ESULTS .&-! PATIENTS REPORTED SIGNIlCANTLY IMPAIRED 1O, IN ALL QUESTIONNAIRES

(21) COMPAREDWITHTHECONTROLSANDTHEAGE ADJUSTEDREFERENCEVALUES!LLSUBSCALESOF FATIGUE

(22) ASSESSED USING THE MULTI DIMENSIONAL &ATIGUE )NDEX GENERAL FATIGUE

(23) PHYSICAL FATIGUE

(24) REDUCTIONINACTIVITY

(25) REDUCTIONINMOTIVATION

(26) MENTALFATIGUE WEREIMPAIRED4HE $IBQUFS. SCORES IN THE .OTTINGHAM (EALTH 0ROlLE POINTED TOWARDS REDUCED ENERGY AND AFFECTED. . EMOTIONAL REACTION )N SEVERAL SUBSCALES OF THE 3HORT &ORM  SOCIAL FUNCTIONING

(27) ROLE LIMITATIONS DUE TO PHYSICAL PROBLEMS

(28) ROLE LIMITATIONS DUE TO EMOTIONAL PROBLEMS AND GENERALHEALTHPERCEPTION .&-!PATIENTSREPORTEDAREDUCED1O, #ONCLUSION1UALITYOF,IFEISCONSIDERABLYREDUCEDINPATIENTSAFTERSUCCESSFULTREATMENT OF.&-!.

(29) 2VBMJUZPGMJGFJTEFDSFBTFEJOQBUJFOUTUSFBUFEGPSOPOGVODUJPOJOHQJUVJUBSZNBDSPBEFOPNB. */530%6$5*0/ .ONFUNCTIONINGPITUITARYMACROADENOMAS.&-! ARETHEMOSTPREVALENTPITUITARYMAC ROADENOMAS   4HE MAIN SYMPTOMS ARE VISUAL lELD DEFECTS AND HYPOPITUITARISM

(30) WHICHARECAUSEDBYMASSEFFECTSOFTHETUMOR4RANSSPHENOIDALSURGERYISCONSIDERED THETREATMENTOFCHOICE

(31) BECAUSEMEDICALTHERAPYINGENERALISINEFFECTIVETOREDUCETUMOR SIZE 6ISUAL lELD DEFECTS IMPROVE IN MORE THAN  OF ALL PATIENTS AFTER SURGERY    )NCONTRAST

(32) HYPOPITUITARISMDOESNOTIMPROVEINMOSTPATIENTSAFTERSURGERYFOR.&-!   4OPREVENTTUMORRECURRENCE

(33) SELECTEDPATIENTSMAYBETREATEDBYPOSTOPERATIVE RADIOTHERAPY  )N GENERAL

(34) PITUITARY DISEASES AREASSOCIATEDWITHIMPAIREDQUALITY OF LIFE 1O,   4HIS CAN BE EXPLAINED BY SEVERAL FACTORS -ACROADENOMAS ARE ASSOCIATED WITH DIFFER ENTDEGREESOFHYPOPITUITARISM

(35) WHICHREQUIREHORMONALSUBSTITUTION(OWEVER

(36) DESPITE OPTIMAL ENDOCRINE REPLACEMENT STRATEGIES

(37) HYPOPITUITARISM IS ASSOCIATED WITH IMPAIRED 1O,PARAMETERS -OREOVER

(38) 'ROWTHHORMONE'( AND!#4(PRODUCINGADENO MASMAYINDUCEIRREVERSIBLEEFFECTS

(39) WHICHPERSISTDESPITELONG TERMCUREOFTHEDISEASE   &INALLY

(40) AN ASSOCIATION BETWEEN APPLIED RADIOTHERAPY AND DECREASED 1O, HAS BEENREPORTED  -OSTSTUDIESON1O,INPITUITARYDISEASESWERENOTFOCUSSEDON.&-!

(41) BUTINCLUDED HETEROGENEOUS GROUPS

(42) CONSISTING OF BOTH FUNCTIONING AND NONFUNCTIONING PITUITARY TU MORS    4O OUR KNOWLEDGE

(43) NO STUDIES ON 1O, IN PATIENTS TREATED FOR .&-!

(44) COMPAREDWITHHEALTHYCONTROLS

(45) HAVEBEENPUBLISHED4HEREFORE

(46) INTHEPRESENTSTUDYTHE AIMWASTOASSESS1O,INADULT.&-!PATIENTSTREATEDBYTRANSSPHENOIDALSURGERY0ATIENT OUTCOMESOF1O,PARAMETERSWERECOMPAREDWITHTHOSEOFCONTROLSUBJECTSASWELLAS TOAGE ADJUSTEDREFERENCEVALUESDERIVEDFROMLITERATURE7EEVALUATEDPHYSICAL

(47) PSYCHO LOGICAL

(48) ANDSOCIALASPECTSOF1O,INPATIENTSAFTERLONG TERMCURE

(49) USINGFOURVALIDATED

(50) HEALTH RELATED1O, QUESTIONNAIRESCOVERINGABROADSPECTRUMOFPHYSICAL

(51) PSYCHOLOGICAL ANDSOCIALHEALTH(!$3

(52) -&) 

(53) 3& AND.(0. 1"5*&/5"/%.&5)0%4. 1SPUPDPM ! TOTAL OF  CONSECUTIVE PATIENTS WITH .&-!

(54) TREATED BY TRANSSPHENOIDAL SURGERY IN OUR CENTER BETWEEN  AND 

(55) WERE IDENTIlED 1O, QUESTIONNAIRES WERE SENT TO THEIRHOMESINPREPAIDENVELOPES!FTERTHREEMONTHSNON RESPONDERSWERECONTACTEDBY TELEPHONETOENCOURAGECOMPLETIONANDRETURNOFTHEQUESTIONNAIRES%ACHPATIENTWAS ALSOASKEDTOPROVIDEACONTROLPERSONOFCOMPARABLEAGEANDSEXTOSERVEASACONTROL GROUP WITH A COMPARABLE SOCIO ECONOMIC STATUS DERIVED FROM THE SAME GEOGRAPHICAL. .

(56) AREA)NADDITIONTOTHISCONTROLGROUP

(57) WEUSEDREFERENCEDATAFROMHEALTHYSUBJECTSOF THE$UTCHANDWEST%UROPEANPOPULATION

(58) OBTAINEDFROMSTUDIESREPORTINGNORMALAGE ADJUSTEDVALUES   !LLPATIENTSWERESEENATLEASTTWICEYEARLYBYANENDOCRINOLOGIST

(59) WITHADEQUATEEVALU ATIONANDTREATMENTOFPOSSIBLEDElCIENCIES OFPITUITARYHORMONES%VALUATIONOF!#4( DElCIENCYAND'(DElCIENCYWASPERFORMED BYINSULIN TOLERANCETEST0REVIOUSSTUDIES HAVEDEMONSTRATEDTHATPATIENTSWITHMULTIPLEPITUITARYHORMONEDElCIENCIES

(60) INCLUDING TWOORMOREPITUITARYHORMONEDElCIENCIESOTHERTHAN'(DElCIENCY

(61) HADALIKELIHOODOF APPROXIMATELYOFHARBOURING'(DElCIENCY  "ASEDONTHESEDATA

(62) WECLASSI lEDPATIENTSINWHOM'( STIMULATIONTESTDATAWERELACKING

(63) BUTWHOWEREDElCIENTIN OTHERPITUITARYAXES

(64) AS'(DElCIENT)NADDITION

(65) THEBIANNUALEVALUATIONCONSISTED OF MEASUREMENTOFFREE4ANDTESTOSTERONEMALEPATIENTS )FRESULTSWEREBELOWTHELOWER LIMITOFTHERESPECTIVEREFERENCE RANGES

(66) SUBSTITUTIONWITHTHYROXINEORTESTOSTERONEWAS STARTED )N THE CASE OF AMENORRHEA AND LOW ESTRADIOL LEVELS IN PREMENOPAUSAL WOMEN

(67) ESTROGENREPLACEMENTWASPROVIDED 4HEMEDICALETHICSCOMMITTEEOFTHE,EIDEN5NIVERSITY-EDICAL#ENTREAPPROVEDTHE. $IBQUFS. STUDYPROTOCOL. . 1BUJFOUTBOEDPOUSPMT 5BCMF. /NE HUNDRED AND SIXTEENOF PATIENTSRETURNEDTHEQUESTIONNAIRES

(68) OFWHOM PREFERREDNOTTOPARTICIPATE4WELVEPATIENTSDIDNOTRESPOND4HUS

(69) COMPLETEDQUES TIONNAIRESWERERECEIVED 4HESTUDY POPULATIONHADAMEANAGEOFYR

(70) RANGE  YR .OSIGNIlCANTDIFFERENCESINAGE

(71) GENDERANDTUMORCHARACTERISTICSWEREFOUND BETWEENTHESTUDY POPULATION

(72) ANDTHEPATIENTSWHOPREFERREDNOTTOPARTICIPATEORWHO DIDNOTRETURNTHEQUESTIONNAIRES 3IXTY SIXCONTROLSWEREPROVIDEDBYTHEPATIENTSWHORETURNEDTHEQUESTIONNAIRES   4HE CONTROL GROUP WAS EXTENDED BY CONTROLS DERIVED FROM OTHER STUDIES IN OUR CENTER

(73) WHOHADBEENSIMILARLYAPPROACHED 4HETOTALCONTROLGROUPCONSISTEDOF CONTROLSMALES

(74) FEMALES

(75) WITHAMEANAGEOFYR

(76) RANGE YR!GEAND GENDER FROM THE CONTROL GROUP WERE NOT SIGNIlCANTLY DIFFERENT FROM THE STUDIED .&-! PATIENTS. 4UVEZQBSBNFUFST 0RIMARYSTUDY PARAMETERSWERETHERESULTSOFTHEFOURHEALTH RELATED1O,QUESTIONNAIRES 4HE RESULTS WERE LINKED TO CHARACTERISTICS AGE AND GENDER OF THE PATIENTS

(77) TREATMENT CHARACTERISTICSSURGERY

(78) RADIOTHERAPY

(79) ANDMULTIPLESURGICALPROCEDURES

(80) THEPRESENCEOF PITUITARYDElCIENCIESANDVISUALlELDDEFECTS.

(81) 2VBMJUZPGMJGFJTEFDSFBTFEJOQBUJFOUTUSFBUFEGPSOPOGVODUJPOJOHQJUVJUBSZNBDSPBEFOPNB. 2VFTUJPOOBJSFT (!$3(OSPITAL!NXIETYAND$EPRESSION3CALE 4HE(!$3CONSISTSOFITEMSPER TAININGTOANXIETYANDDEPRESSION%ACHITEMISMEASUREDONAFOUR POINTSCALE3CORESFOR THEANXIETYANDDEPRESSIONSUBSCALERANGEFROM ANDFORTHETOTALSCOREFROM ! HIGHSCOREPOINTSTOMORESEVEREANXIETYANDDEPRESSION !TOTALSCOREOFORMORE WASCONSIDEREDINCREASED!GE RELATED$UTCHREFERENCEVALUESOFTHEGENERALPOPULATION WEREDERIVEDFROMTHESTUDYOF3PINHOVENETAL  -&)  -ULTIDIMENSIONAL &ATIGUE )NDEX 4HE -&)  CONTAINS  STATEMENTS TO ASSESSFATIGUE &IVEDIFFERENTDIMENSIONSOFFATIGUEFOURITEMSEACH ARECALCULATED FROMTHESESTATEMENTS GENERALFATIGUE

(82)  PHYSICALFATIGUE

(83)  REDUCEDACTIVITY

(84)  RE DUCEDMOTIVATION

(85) AND MENTALFATIGUE%VERYSTATEMENTISMEASUREDONA POINTSCALE SCORESVARYFROMTO(IGHERSCORESINDICATEHIGHEREXPERIENCEDFATIGUE!GE RELATED $UTCHREFERENCEVALUESWEREDERIVEDFROM3METSETAL  .(0 .OTTINGHAM (EALTH 0ROlLE 4HE .(0 IS FREQUENTLY USED IN PATIENTS WITH PITUITARYDISEASETOASSESSGENERALWELL BEINGAND1O,4HESURVEYCONSISTSOFYESNO QUESTIONS

(86) WHICH ARE SUBDIVIDED IN  SCALES ASSESSING IMPAIRMENTS

(87) IE PAIN  ITEMS

(88) ENERGYLEVELITEMS

(89) SLEEPITEMS

(90) EMOTIONALREACTIONSITEMS

(91) SOCIALISOLATION ITEMS ANDDISABILITYFUNCTIONING

(92) IEPHYSICALMOBILITYITEMS  3UBSCALESCORES ARECALCULATEDASAWEIGHTEDMEANOFTHEASSOCIATEDITEMSANDAREEXPRESSEDASAVALUE BETWEENAND4HETOTALSCOREISTHEMEANOFTHESUBSCALES!HIGHSCOREISRELATED TOAWORSE1O,!GE RELATED7EST %UROPEANREFERENCEVALUESWEREDERIVEDFROMTHESTUDY FROM(INZETAL  3&  3HORT &ORM  4HE 3&  QUESTIONNAIRE COMPRISES  ITEMS AND RECORDS GENERAL WELL BEING DURING THE PREVIOUS  DAYS   4HE ITEMS ARE FORMULATED AS STATEMENTSORQUESTIONSTOASSESSEIGHTHEALTHCONCEPTS PHYSICALFUNCTIONING

(93)  SOCIAL FUNCTIONING

(94)  LIMITATIONSINUSUALROLEACTIVITIESBECAUSEOFPHYSICALHEALTHPROBLEMS

(95)  PAIN

(96)  GENERALMENTALHEALTHPSYCHOLOGICALDISTRESSANDWELL BEING

(97)  LIMITATIONSIN USUALROLEACTIVITIESBECAUSEOFEMOTIONALPROBLEMS

(98)  VITALITYENERGYANDFATIGUE

(99) AND  GENERALHEALTHPERCEPTIONSANDCHANGEINHEALTH"ECAUSETHE(!$3ANDTHE-&)  AREMORESPECIlCQUESTIONNAIRESFORMENTALHEALTHANDFATIGUE

(100) THEVITALITYANDGENERAL MENTALHEALTHITEMSWERELEFTOUTINTHISEVALUATION"ECAUSETHESCORESFORTHEITEMS ARE CALCULATED SEPARATELY FROM EXCLUSIVE ITEM SPECIlC QUESTIONS 

(101) THE RESULTS OF THE 3& ITEMSPRESENTEDINTHISSTUDYARENOTINmUENCEDBYTHEITEMSWELEFTOUTINTHIS EVALUATION 3CORES ARE EXPRESSED ON A   SCALE (IGHER SCORES ARE ASSOCIATED WITH BETTER 1O, !GE RELATED 7EST %UROPEAN REFERENCE VALUES WERE DERIVED FROM THE $UTCH MANUAL . .

(102) 4UBUJTUJDT 3033FORWINDOWSVERSION3033)NC

(103) #HICAGO

(104) ), WASUSEDFORDATAANALYSIS$ATA ARE EXPRESSED AS MEAN ¢ 3$

(105) UNLESS OTHERWISE MENTIONED 7E USED UNPAIRED 4 TESTS TO COMPARE PATIENT AND CONTROL DATA 5SING STEPWISE LINEAR REGRESSION ANALYSIS WE AS SESSED INDEPENDENT VARIABLES THAT AFFECT 1O, 2ESULTS OF THE LINEAR REGRESSION ANALYSIS AREEXPRESSEDASTHEABSOLUTESTANDARDIZED`OFINDEPENDENTPREDICTIVEFACTORS/NE WAY !./6!ANALYSISWASPERFORMEDTOCOMPARE1O,SCORESOFTHREEDIFFERENTGROUPS0ATIENTS WITHOUT'(DElCIENCY

(106) PATIENTSWITH'(DElCIENCY

(107) SUBSTITUTEDWITHRECOMBINANTHUMAN RH '( AND PATIENTS WITH '( DElCIENCY WITHOUT RH'H SUBSTITUTION  $IFFERENCES WERE CONSIDEREDSTATISTICALLYSIGNIlCANTAT0. 3&46-54. 1BUJFOUBOEUSFBUNFOUDIBSBDUFSJTUJDT 5BCMF. 0ATIENTCHARACTERISTICSAREDETAILEDIN4ABLE!LLPATIENTSHADBEENTREATEDBYTRANS SPHENOIDAL SURGERY 4WENTY TWO PATIENTS HAD RECEIVED PROPHYLACTIC POSTOPERATIVE RA $IBQUFS. DIOTHERAPY 2EPEAT SURGERY WITHIN  MONTHS AFTER INITIAL TREATMENT WAS PERFORMED IN . . PATIENTSFORALARGERESIDUALTUMORMASSN

(108) PERSISTINGLIQUORLEAKAGEN ORPROFUSE BLEEDINGN 4HEMEANFOLLOW UPPERIODAFTERINITIALSURGICALTREATMENTWAS¢ YR)NPATIENTSTUMORRECURRENCEWASOBSERVEDBY-2)SCANNING

(109) AFTERAMEANFOLLOW UPDURATIONOF¢YR4UMORRECURRENCEWASTREATEDBYRADIOTHERAPYN

(110) ORA COMBINATIONOFSURGERYANDRADIOTHERAPYN )NTHEREMAININGPATIENTSANEXPECTANT APPROACHWASUNDERTAKEN !TTHETIMEOFEVALUATION

(111) OFTHEPATIENTSWERE'(DElCIENT

(112) WERE,(&3(DE lCIENT

(113) WERE!#4(DElCIENTANDWERE43(DElCIENT(YPOPITUITARISM

(114) DElNED ASPITUITARYDElCIENCYINATLEASTONEAXIS

(115) WASPRESENTINOFPATIENTS

(116) PANHYPOPI TUITARISMOFTHEANTERIORPITUITARYGLANDIN$IABETESINSIPIDUSWASPRESENTINOF THEPATIENTS!LLPATIENTSWITH!#4(AND43(DElCIENCYRECEIVEDHORMONALSUBSTITUTION THERAPY/FALL'(DElCIENTPATIENTS

(117)  RECEIVEDRH'HSUBSTITUTIONATTHETIMEOF EVALUATION/FALL'(DElCIENTPATIENTSWITHOUTSUBSTITUTIONATTIMEOFEVALUATION

(118) RH'( WASSTOPPEDINCASES &INALLY

(119) VISUALlELDDEFECTSWEREPRESENTINOFCASES. 2VBMJUZPG-JGFJO/'."QBUJFOUTDPNQBSFEXJUIDPOUSPMTBOEBHFBEKVTUFESFGFSFODFWBMVFT 5BCMF  .&-!PATIENTSREPORTEDANIMPAIRED1O,COMPAREDWITHTHECONTROLSANDTHEAGE ADJUSTED REFERENCE VALUES 4HE 1O, SCORES WERE SIGNIlCANTLY REDUCED IN  OUT OF  SUBSCALESASCOMPAREDWITHOWNCONTROLS

(120) ANDINOUTOFSUBSCALESASCOMPARED WITHAGEADJUSTEDREFERENCEVALUES.

(121) 2VBMJUZPGMJGFJTEFDSFBTFEJOQBUJFOUTUSFBUFEGPSOPOGVODUJPOJOHQJUVJUBSZNBDSPBEFOPNB. 4ABLE#HARACTERISTICSOF.&-!PATIENTSANDCONTROLS. "HF ZS. 4FY .'. "HFBUEJBHOPTJT 1JUVJUBSZGVODUJPO ()EFmDJFODZ .FBO*('*4%TDPSFJOSI()TVCTUJUVUFEQBUJFOUT .FBO*'(*4%TDPSFJO()EFmDJFOU OPOTVCTUJUVUFEQBUJFOUT -)'4)EFmDJFODZ "$5)EFmDJFODZ .FBOEBJMZEPTFPGIZESPDPSUJTPOF NH JOTVCTUJUVUFEQBUJFOUT 54)EFmDJFODZ .FBOGSFF5MFWFMT QNPM- JOTVCTUJUVUFEQBUJFOUT OPSNBM. "OZEFHSFFPGIZQPQJUVJUBSJTN 5XPPSNPSFQJUVJUBSZEFmDJFODJFT 1BOIZQPQJUVJUBSJTNPGUIFBOUFSJPSQJUVJUBSZHMBOE %JBCFUFTJOTJQJEVT (FOFSBMNFEJDBMJMMOFTTBOEEJTBCJMJUZ 7JTVBMmFMEEFGFDUT %JBCFUFT.FMMJUVT $BSEJPWBTDVMBSEJTFBTF +PJOUDPNQMBJOUT. /'."1BUJFOUT /.  SBOHF  (. $POUSPMT /.  SBOHF .  œ œ   œ  œ        . #OMPAREDWITHOWNCONTROLS

(122) INPATIENTSWITH.&-!

(123) ALLSUBSCALESOFTHE-&) 

(124) AS SESSINGDIFFERENTASPECTSOFENERGYFATIGUE

(125) WEREAFFECTED4HEMAJORITYOFITEMSASSESSED BYTHE3& ANDTHE.(0

(126) TWOQUESTIONNAIRESCOVERINGMULTIPLEASPECTSOFGENERALHEALTH ANDWELL BEING

(127) WEREAFFECTEDWITHTHEEXCEPTIONOFPAIN.(0AND3&  ANDHEALTH CHANGE 3&   /N THE  SUBSCALES OF THE (!$3

(128) .&-! PATIENTS PERFORMED WORSE COMPAREDWITHOWNCONTROLS #OMPAREDWITHAGE ADJUSTEDREFERENCEVALUES

(129) THEMAJORITYOFSUBSCALESOFTHE-&)  WEREAFFECTED

(130) WITHTHEEXCEPTIONOFGENERALFATIGUE!CCORDINGTOTHE3& SCORESOF OUTOFSUBSCALESWEREREDUCEDSOCIALFUNCTIONING

(131) ROLELIMITATIONSDUEPHYSICAL

(132) EMO TIONALPROBLEMSANDGENERALHEALTHPERCEPTION /NLYTWOSUBSCALESOFTHE.(0ENERGY ANDEMOTIONALREACTION POINTEDTOWARDAREDUCED1O,IN.&-!PATIENTS4HEREWASNO SIGNIlCANTLY AFFECTED 1O, PARAMETER ACCORDING TO THE (!$3 QUESTIONNAIRE

(133) COMPARED WITHAGEADJUSTEDREFERENCEVALUES. 5IFFõFDUPG()EFmDJFODZBOE()SFQMBDFNFOUPO2P!SUBSTANTIALPROPORTION OFTHE.&-!PATIENTSWITH'(DElCIENCYWERENOTSUB STITUTEDWITHRH'(4OASSESSTHEEFFECTOF'(DElCIENCYANDRH'(REPLACEMENTON1O,

(134) WEPERFORMED!./6!ANALYSISCOMPARINGTHREEGROUPSPATIENTSWITHOUT'(DElCIENCY N

(135) PATIENTSWITH'(DElCIENCY

(136) SUBSTITUTEDWITHRH'(N ANDPATIENTSWITH'( DElCIENCY

(137) BUTWITHOUTRH'HSUBSTITUTIONN 4HEONLYSIGNIlCANTDIFFERENCEBETWEEN. .

(138) 4ABLE1UALITYOF,IFEPARAMETERS(!$3

(139) -&) 

(140) .(0

(141) 3&  INTREATED.&!PATIENTSCOMPAREDWITH CONTROLSANDAGE ADJUSTEDREFERENCEVALUES. $IBQUFS. )"%4 "OYJFUZ %FQSFTTJPO 5PUBM .'* (FOFSBMGBUJHVF 1IZTJDBMGBUJHVF 3FEVDUJPOJOBDUJWJUZ 3FEVDUJPOJONPUJWBUJPO .FOUBM'BUJHVF /)1 &OFSHZ 1BJO &NPUJPOBMSFBDUJPO 4MFFQ 1IZTJDBMNPCJMJUZ 4PDJBMJTPMBUJPO 4' 1IZTJDBMGVODUJPOJOH 4PDJBMGVODUJPOJOH 3PMFMJNJUBUJPOTEVFUPQIZTJDBMQSPCMFNT 3PMFMJNJUBUJPOTEVFUPFNPUJPOBMQSPCMFNT 1BJO (FOFSBMIFBMUIQFSDFQUJPO )FBMUIDIBOHF. . /'"QBUJFOUT O. $POUSPMT O. QWBMVF. "HFBEKVTUFE SFGFSFODFWBMVFT. QWBMVF. œ œ œ. œ œ œ.   . œ œ œ. OT OT OT. œ œ œ œ œ. œ œ œ œ œ.     . œ œ œ œ œ. OT    . œ œ œ œ œ œ. œ œ œ œ œ œ.  OT    . œ œ œ œ  œ œ.  OT  OT OT OT. œ œ œ œ œ œ œ. œ œ œ œ œ œ œ.     OT  OT. œ œ œ œ œ œ œ. OT    OT  OT. . PATIENTSCOMPAREDWITHOWNCONTROLS DERIVEDFROMREFERENCES   PATIENTSCOMPAREDWITHLITERATUREREFERENCEDATA . THESETHREEGROUPSWASINSLEEPPERFORMANCE.(0

(142) 0 3LEEPWASMOSTAFFECTEDIN PATIENTSWITHA'(DElCIENCY

(143) SUBSTITUTEDWITHRH'(. -JOFBSSFHSFTTJPO 3TEPWISEUNI VARIATELINEARREGRESSIONANALYSISWASPERFORMEDINAMODELINCLUDINGGEN DER

(144) AGE

(145) RADIOTHERAPY

(146) MULTIPLE OPERATIONS

(147) !#4( DElCIENCY

(148) 43( DElCIENCY

(149) ,(&3( DElCIENCY

(150) '(DElCIENCY

(151) MULTIPLEPITUITARYDElCIENCIESANDVISUALDEFECTSASINDEPEN DENTVARIABLES

(152) ANDTHEQUESTIONNAIREITEMSASDEPENDENTVARIABLES !GEWASANINDEPENDENTPREDICTORFORREDUCEDPHYSICALABILITY.(0

(153) STANDARDIZED` 

(154) 0 ANDREDUCEDPHYSICALFUNCTION3& 

(155) STANDARDIZED`

(156) 0 4HE PRESENCEOFMULTIPLEHORMONALDElCIENCIESWASANINDEPENDENTPREDICTORFORROLELIMITA TIONSDUETOPHYSICALPROBLEMS3& 

(157) STANDARDIZED`

(158) 0

(159) IMPAIREDSOCIAL FUNCTIONING3& 

(160) STANDARDIZED`

(161) 0 ANDSLEEP.(0

(162) STANDARDIZED` 

(163) 0 ANDINCREASEDGENERALFATIGUE-&) 

(164) STANDARDIZED`

(165) 0 ,(.

(166) 2VBMJUZPGMJGFJTEFDSFBTFEJOQBUJFOUTUSFBUFEGPSOPOGVODUJPOJOHQJUVJUBSZNBDSPBEFOPNB. &3(DElCIENCYWASANINDEPENDENTPREDICTORFORREDUCEDACTIVITY-&) 

(167) STANDARDIZED` 

(168) 0 ANDINCREASEDPHYSICALFATIGUE-&) 

(169) STANDARDIZED`

(170) 0  &EMALEGENDERWASANINDEPENDENTPREDICTORFORINCREASEDANXIETY(!$3

(171) STANDARDIZED `

(172) P 2ADIOTHERAPY

(173) VISUALlELDDEFECTSAND'(DElCIENCYWERENOTFOUND TOBEINDEPENDENTPREDICTORSFORREDUCED1O,INANYOFTHEQUESTIONNAIRES. %*4$644*0/ 4HE DATA IN THIS STUDY INDICATE THAT QUALITY OF LIFE IS REDUCED IN PATIENTS SUCCESSFULLY TREATEDFOR.&-!!CCORDINGTOTHEPARAMETERSTESTEDBYTHE(!$3

(174) -&) 

(175) .(0AND3& QUESTIONNAIRES

(176) PATIENTSREPORTEDADECREASED1O,INOUTOFSUBSCALES

(177) COMPARED WITHBOTHAGE ADJUSTEDREFERENCEVALUESANDCONTROLS!LMOSTALLSUBSCALESOFTHE-&) 

(178) ASSESSINGENERGYFATIGUE

(179) SHOWEDASIGNIlCANTDECREASED1O,,INEARREGRESSIONANALYSIS REVEALEDTHEPRESENCEOFMULTIPLEPITUITARYDElCIENCIES

(180) AND

(181) TOALESSEREXTENTAGE

(182) ASTHE PREDOMINANTPREDICTORSOFADECREASED1O, )NTHEPRESENTSTUDY

(183) .&-!PATIENTSWERECOMPAREDWITHOWNCONTROLSANDAGE ADJUST EDREFERENCEVALUESDERIVEDFROMLITERATURE4HEADVANTAGEOFUSINGOWNCONTROLSISTHAT THEYAREFROMTHESAMEGEOGRAPHICAREAANDSOCIO ECONOMICCLASSASTHEPATIENTS  (OWEVER

(184) THESECONTROLSMIGHTBESUBJECTTOASELECTIONBIAS

(185) BECAUSEPATIENTSMIGHTHAVE CHOSENCONTROLSWITHASUPPOSEDGOODHEALTHSTATUS 4OOVERCOMETHISPOTENTIALBIAS

(186) WEALSOCOMPAREDTHE.&-!PATIENTSTOAGE ADJUSTEDREFERENCEVALUESFROMTHELITERATURE -OREOVER

(187) THEUSEOFTWODIFFERENTCONTROLGROUPSMIGHTLEADTOMORECREDIBLERESULTSIF THERESULTSARECONSISTENT 4HESCORESOFTHE.&-!PATIENTSSHOWEDANIMPAIRED1O, INMORESUBSCALESOFTHEFOURQUESTIONNAIRES

(188) COMPAREDWITHOWNCONTROLSTHANCOMPARED WITHTHEAGE ADJUSTEDREFERENCE VALUES

(189) CONlRMINGTHEPOSSIBLEDIFFERENCEINHEALTHSTATUS BETWEENTHETWOGROUPS.ONETHELESS

(190) EVENCOMPAREDWITHTHEREFERENCEDATAOBTAINED FROM THE LITERATURE

(191) OUR .&-! PATIENTS SCORED WORSE

(192) SUPPORTING OUR CONCLUSIONS WITH RESPECTTOTHENEGATIVEEFFECTOF.&-!ON1O,!LTHOUGHTHERESPONSERATEINOURSERIES OFPATIENTSWITH.&-!WAS

(193) ANDCOMPLETEDQUESTIONNAIRESWERERECEIVEDOFOF THEPATIENTS

(194) ITSEEMSUNLIKELY

(195) THATTHENON RESPONDERSHAVEINmUENCEDTHEOUTCOMEOF OURSTUDY

(196) BECAUSETHEREWERENODIFFERENCESINPATIENTCHARACTERISTICSBETWEENRESPOND ERSANDNON RESPONDERSDECLINERS ,ITERATUREON1O,INPATIENTSWITH.&-!ISSCARCE4OOURKNOWLEDGEONLYTWOSTUDIES EVALUATED1O,IN.&-!PATIENTS *OHNSONETALREPORTEDAREDUCED1O,IN.&-! PATIENTS

(197) BEFORETREATMENT

(198) USINGTHE3& QUESTIONNAIRE

(199) COMPAREDWITHSCORESFROMTHE NORMAL POPULATION   /THER REPORTS ON 1O, IN .&-!

(200) CONSISTING OF HETEROGENEOUS GROUPSOFPATIENTSWITHBOTHFUNCTIONINGANDNONFUNCTIONINGTUMORS

(201) SHOWEDAREDUCED 1O,INPATIENTSWITHPITUITARYTUMORSINGENERAL (OWEVER

(202) ITWASNOTPOSSIBLE. .

(203) 4ABLE3UMMARYOF3& RESULTSINPATIENTSTREATEDFORNONFUNCTIONINGPITUITARYMACROADENOMASANDIN PATIENTSAFTERMASTOIDSURGERY. .FBOBHF ZS. 1IZTJDBMGVODUJPOJOH 1IZTJDBMSPMF &NPUJPOBMSPMF 4PDJBMGVODUJPOJOH #PEJMZQBJO )FBMUIQFSDFQUJPO. /'"USFBUFE PXOEBUB.  œ œ œ œ œ œ. .BTUPJETVSHFSZ .  œ œ œ œ œ œ. TOPERFORMSUBGROUPANALYSISINORDERTOESTIMATE1O,SPECIlCALLYIN.&-!

(204) BECAUSEOF THESMALLNUMBEROFPATIENTS -OREOVER

(205) THEEFFECTSOFPITUITARYDISEASESON1O, CANNOTSIMPLYBEGENERALIZEDFORALLPITUITARYDISEASES.&-!PATIENTSDIFFERFROMPATIENTS WITHFUNCTIONINGPITUITARYADENOMASINSEVERALASPECTS.&-!ISMOREPREVALENTINOLDER AND MALE PATIENTS COMPARED WITH FUNCTIONING PITUITARY ADENOMAS   .ONFUNCTION ING ADENOMAS ARE TREATED ONLY WHEN TUMOR SIZE INDICATES A MACROADENOMA

(206) WHEREAS TREATMENTINDICATIONINFUNCTIONINGADENOMASISFOCUSEDATHORMONEOVERPRODUCTIONIN $IBQUFS. ADDITIONTOTUMORSIZE4HEREFORE

(207) PITUITARYTUMORSINTREATED.&-!TENDTOBELARGERTHAN. . TUMORSINPATIENTSTREATEDFORFUNCTIONINGPITUITARYADENOMAS)NACCORDANCE

(208) IN.&-! PATIENTSTHEREISAHIGHERDEGREEOFPITUITARYDElCIENCIES

(209) WHEREASPATIENTSCUREDFROM FUNCTIONING PITUITARY TUMORS ALSO SUFFER FROM IRREVERSIBLE EFFECTS OF PREVIOUS HORMONE OVERPRODUCTION

(210) AS IS THE CASE IN FUNCTIONING ADENOMAS SUCH AS #USHINGS DISEASE OR ACROMEGALY   #OMPARED WITH .&-!

(211) 1O, IN ACROMEGALY PATIENTS IS CLEARLY DE CREASED   1O, ASSESSMENT IN HETEROGENEOUS GROUPS

(212) CONSISTING OF BOTH FUNCTIONING AND NONFUNCTIONING ADENOMAS

(213) MAY THEREFORE NOT BE AN APPROPRIATE STRATEGY TO ASSESS 1O,INPATIENTSTREATEDFOR.&-! 4HESTUDYFROM0AGEETALDIDNOTREVEALAREDUCED1O,INSURGICALLYTREATED.&-! PATIENTS

(214) COMPARED WITH PATIENTS AFTER MASTOID SURGERY   4HE RESULTS OF THE 3&  QUESTIONNAIREFROMTHESEPATIENTSAFTERMASTOIDSURGERYARESUMMARIZEDIN4ABLE4HESE RESULTSDONOTSHOWCONCORDANTDIFFERENCESCOMPAREDWITHOUR.&-!PATIENTS

(215) POINTING TOWARDAGENERALROLEFORMEDICALILLNESSINIMPAIRED1O,(OWEVER

(216) THISALSOUNDERSCORES THENOTIONTHATTHE3& QUESTIONNAIREISNOTDISEASE SPECIlC

(217) IEISNOTSPECIlCFORTHE ASSESSMENTOF1O,INPATIENTSWITHPITUITARYDISEASES /URRESULTSPOINTTOWARDAREDUCED1O,INPHYSICALANDPSYCHOLOGICALASWELLSOCIAL ITEMS4REATED.&-!PATIENTSREPORTINCREASEDFATIGUE

(218) BOTHMENTALANDPHYSICAL

(219) REDUCED ENERGYANDROLELIMITATIONSDUETOPHYSICALPROBLEMSASWELLASREDUCEDACTIVITYANDRE DUCEDMOTIVATION)NTERESTINGLY

(220) PHYSICALFUNCTIONINGSEEMEDNOTTOBEAFFECTEDCOMPARED WITHAGEADJUSTEDREFERENCEVALUES.&-!PATIENTSALSOREPORTAFFECTEDEMOTIONALREAC TIONS

(221) ROLELIMITATIONSDUETOEMOTIONALPROBLEMSASWELLASAFFECTEDSOCIALFUNCTIONING.

(222) 2VBMJUZPGMJGFJTEFDSFBTFEJOQBUJFOUTUSFBUFEGPSOPOGVODUJPOJOHQJUVJUBSZNBDSPBEFOPNB. .ONETHELESS

(223) THE(!$3QUESTIONNAIREDIDNOTREVEALANYSIGNIlCANTDIFFERENCEBETWEEN .&-!PATIENTSANDAGE ADJUSTEDREFERENCEVALUES4HISlNDINGISINACCORDANCEWITHTHE REPORTOF+ORALIETALINWHICHNOELEVATEDRATESOFMENTALDISORDERSCOULDBEFOUNDAFTER TREATMENTFOR.&-!

(224) EVENINTHECASEOFMULTIPLEPITUITARYDElCIENCIES  7E COULD NOT PROPERLY ASSESS THE EFFECT OF HYPOPITUITARISM PER SE ON 1O,

(225) BECAUSE HYPOPITUITARISMWASPRESENTINOFALL.&-!PATIENTS!LTHOUGHTHENUMBEROFPA TIENTSWITHHYPOPITUITARISMSEEMSRATHERHIGH

(226) ITISCOMPARABLETOTHEPERCENTAGE OFPATIENTSWITHHYPOPITUITARISMPRESENTEDINASERIESOFCONSECUTIVEPATIENTSTREATEDFOR .&-!INOURHOSPITAL 4HEPATIENTPOPULATIONINTHEPRESENTSERIESSEEMSTHEREFORE NOTSKEWEDTOWARDSTHOSEPATIENTSWITHMORESEVEREDISEASE(YPOPITUITARISMWASFOUND TOBEANINDEPENDENTPREDICTOROFREDUCED1O,INPATIENTSTREATEDFOR#USHINGSDISEASE

(227) AFFECTINGBOTHPHYSICALANDPSYCHOSOCIALITEMS )NTHEPRESENTSTUDY

(228) THEPRESENCE OFMULTIPLEPITUITARYDElCIENCIESWASTHEMOSTPREDOMINANTPREDICTORFORDECREASED1O,

(229) POINTINGTOWARDANIMPORTANTROLEOFPITUITARYFUNCTIONFOROPTIMAL1O,(ORMONALSUB STITUTION THERAPY DOES NOT REPRODUCE THE NORMAL PLASMA HORMONE PROlLES OF HEALTHY INDIVIDUALS-OREOVER

(230) THEEFFECTSOFHORMONESINGENERALAREDIFlCULTTOQUANTIFYATTHE TISSUE LEVEL #ONSEQUENTLY

(231) TITRATION OF ENDOCRINE REPLACEMENT THERAPY IS POSSIBLE ONLY WITHIN CERTAIN PHYSIOLOGICAL LIMITS 4HESE INTRINSIC IMPERFECTIONS IN ENDOCRINE REPLACE MENTTHERAPYMAYRESULTINSUBTLEPHYSIOLOGICALDERANGEMENTS-OSTIMPORTANTLY

(232) THISIM PERFECTIONINENDOCRINESUBSTITUTIONMAYRESULTINADECREASED1O,)NTHISSTUDY,(&3( DElCIENCYWASANINDEPENDENTPREDICTORFORREDUCEDACTIVITYANDINCREASEDPHYSICALFA TIGUE4HISMAYREmECTTHELACKOFSENSITIVESIGNSANDSYMPTOMSFORMONITORINGADEQUACY OF TESTOSTERONE AND ESTROGEN SUBSTITUTION   7E DID NOT MEASURE ROUTINELY LEVELS OF DEHYDROEPIANDROSTENEDIONE $(%!  (OWEVER

(233) WE RECENTLY DOCUMENTED IN A RANDOM IZED PLACEBO CONTROLLED TRIAL

(234) THAT $(%! SUBSTITUTION SUPERIMPOSED ON '( SUBSTITUTION DIDNOTSUBSTANTIALLYIMPROVE1O,INPATIENTSWITHSECONDARYADRENALFAILURE )NTHIS STUDY

(235) FEMALEGENDERWASANINDEPENDENTPREDICTORFORANXIETY4HEPREDISPOSITIONFOR FEMALEGENDERASANINDEPENDENTRISKFACTORFORADECREASED1O,ISUNCLEAR

(236) ANDHASBEEN PREVIOUSLY DESCRIBED IN PATIENTS WITH PRIMARY BRAIN TUMORS   (OWEVER

(237) IT DOES NOT SEEMTOBEADISEASESPECIlCPHENOMENONGIVENTHEFACTTHAT1O,STUDIESINNONPITUITARY DISEASESMALIGNANCIES

(238) CORONARYHEARTDISEASE

(239) INmAMMATORYBOWELDISEASE ALSOREPORT DECREASED1O,INFEMALEPATIENTSASCOMPAREDWITHMALEPATIENTS   '( DElCIENCY WAS NOT FOUND TO BE AN INDEPENDENT PREDICTOR FOR ANY OF SUBSCALES OFTHEFOURQUESTIONNAIRES)NOURSTUDYONLYOFALL'(DElCIENTPATIENTSRECEIVED RH'(SUBSTITUTION7ECOULDNOTDETECTABENElCIALEFFECTOFRH'(SUBSTITUTIONON1O, SCORES(OWEVER

(240) THISSTUDYWAS

(241) INSTRICTSENSE

(242) NOTDESIGNEDTOASSESSTHEEFFECTOFRH'( SUBSTITUTIONON1O,!RECENTMETA ANALYSISONTHEEFFECTOFRH'HSUBSTITUTIONONVARIOUS 1O,SUBSCALES

(243) SUGGESTEDTHATRH'(SUBSTITUTIONDOESNOTIMPROVE1O,COMPAREDWITH PLACEBO -OREOVER

(244) SEVERALSTUDIESREPORTANIMPROVED1O,ANDWELL BEING 

(245) . .

(246) SUGGESTING THAT IN SELECTED PATIENTS RH'( SUBSTITUTION MAY HAVE A BENElCIAL EFFECT ON 1O,  4HEFOURHEALTH RELATEDQUESTIONNAIRESUSEDINTHISSTUDY

(247) WERENOTDISEASE SPECIlC

(248) IE THEYWERENOTDEVELOPEDTOASSESS1O,IN.&-!

(249) ALTHOUGHTHE.(0ISFREQUENTLYUSEDIN PATIENTSWITHPITUITARYDISEASE(OWEVER

(250) WEFOUNDAREDUCED1O,INTHEMAJORITYOFSUB SCALESOFTHE-&) 

(251) THE3& ANDTHE.(04HISSEEMSTOPOINTTOWARDASTRONGOVERALL EFFECTOFTHEPITUITARYDISEASESONGENERALHEALTHANDWELLBEINGOFBOTHTHEPHYSICALAND THEPSYCHOSOCIALASPECTS )NCONCLUSION

(252) 1UALITYOF,IFEISREDUCEDINPATIENTSAFTERSUCCESSFULTREATMENTOF.&-! !CCORDINGTOTHE-&) 

(253) .(0AND3& 

(254) PATIENTSREPORTEDADECREASED1O,INALMOST ALLSUBSCALESCOMPAREDWITHAGE ADJUSTEDREFERENCEVALUESANDCONTROLS4HEPRESENCEOF. $IBQUFS. MULTIPLEPITUITARYDElCIENCIESWASTHEPREDOMINANTPREDICTORFORAREDUCED1O,. .

(255) 2VBMJUZPGMJGFJTEFDSFBTFEJOQBUJFOUTUSFBUFEGPSOPOGVODUJPOJOHQJUVJUBSZNBDSPBEFOPNB. 3&'&3&/$&4  &ELDKAMP*

(256) 3ANTEN2

(257) (ARMS%

(258) !ULICH!

(259) -ODDER5

(260) 3CHERBAUM7!)NCIDENTALLYDISCOVERED PITUITARYLESIONSHIGHFREQUENCYOFMACROADENOMASANDHORMONE SECRETINGADENOMASnRE SULTSOFAPROSPECTIVESTUDY#LIN%NDOCRINOL/XF     -C#OMB $*

(261) 2YAN .

(262) (ORVATH %

(263) +OVACS + 3UBCLINICAL ADENOMAS OF THE HUMAN PITUITARY .EWLIGHTONOLDPROBLEMS!RCH0ATHOL,AB-ED    #OMTOIS2

(264) "EAUREGARD(

(265) 3OMMA-

(266) 3ERRI/

(267) !RIS *ILWAN.

(268) (ARDY*4HECLINICALANDENDO CRINEOUTCOMETOTRANS SPHENOIDALMICROSURGERYOFNONSECRETINGPITUITARYADENOMAS#ANCER     %BERSOLD-*

(269) 1UAST,-

(270) ,AWS%2

(271) *R

(272) 3CHEITHAUER"

(273) 2ANDALL26,ONG TERMRESULTSINTRANS SPHENOIDALREMOVALOFNONFUNCTIONINGPITUITARYADENOMAS*.EUROSURG    -ARAZUELA -

(274) !STIGARRAGA "

(275) 6ICENTE ! ET AL 2ECOVERY OF VISUAL AND ENDOCRINE FUNCTION FOLLOWINGTRANSSPHENOIDALSURGERYOFLARGENONFUNCTIONINGPITUITARYADENOMAS*%NDOCRINOL )NVEST    3CHEITHAUER"7

(276) *AAP!*

(277) (ORVATH%ETAL#LINICALLYSILENTCORTICOTROPHTUMORSOFTHEPITUITARY GLAND.EUROSURGERY    'REENMAN9

(278) 4ORDJMAN+

(279) +ISCH%

(280) 2AZON.

(281) /UAKNINE'

(282) 3TERN.2ELATIVESPARINGOFANTERIOR PITUITARY FUNCTION IN PATIENTS WITH GROWTH HORMONE SECRETING MACROADENOMAS COMPARISON WITHNONFUNCTIONINGMACROADENOMAS*#LIN%NDOCRINOL-ETAB    .OMIKOS 0

(283) ,ADAR #

(284) &AHLBUSCH 2

(285) "UCHFELDER - )MPACT OF PRIMARY SURGERY ON PITUITARY FUNCTIONINPATIENTSWITHNONFUNCTIONINGPITUITARYADENOMASnASTUDYONPATIENTS!CTA .EUROCHIR7IEN     7ICHERS 2OTHER-

(286) (OVEN3

(287) +RISTOF2!

(288) "LIESENER.

(289) 3TOFFEL 7AGNER".ONFUNCTIONINGPITU ITARYADENOMASENDOCRINOLOGICALANDCLINICALOUTCOMEAFTERTRANSSPHENOIDALANDTRANSCRANIAL SURGERY%XP#LIN%NDOCRINOL$IABETES    0ARK0

(290) #HANDLER7&

(291) "ARKAN!,ETAL4HEROLEOFRADIATIONTHERAPYAFTERSURGICALRESECTIONOF NONFUNCTIONALPITUITARYMACROADENOMAS.EUROSURGERY    *OHNSON-$

(292) 7OODBURN#*

(293) 6ANCE-,1UALITYOFLIFEINPATIENTSWITHAPITUITARYADENOMA 0ITUITARY    "IERMASZ .2

(294) VAN 4HIEL 37

(295) 0EREIRA !- ET AL $ECREASED QUALITY OF LIFE IN PATIENTS WITH ACROMEGALYDESPITELONG TERMCUREOFGROWTHHORMONEEXCESS*#LIN%NDOCRINOL-ETAB     VAN !KEN -/

(296) 0EREIRA !-

(297) "IERMASZ .2 ET AL 1UALITY OF LIFE IN PATIENTS AFTER LONG TERM BIOCHEMICALCUREOF#USHINGSDISEASE*#LIN%NDOCRINOL-ETAB    0AGE2#

(298) (AMMERSLEY-3

(299) "URKE#7

(300) 7ASS*!!NACCOUNTOFTHEQUALITYOFLIFEOFPATIENTS AFTERTREATMENTFORNONFUNCTIONINGPITUITARYTUMOURS#LIN%NDOCRINOL/XF     "AIRD!

(301) 3ULLIVAN4

(302) :AFAR3

(303) 2OCK*1UALITYOFLIFEINPATIENTSWITHPITUITARYTUMORSAPRELIMI NARYSTUDY1UAL-ANAG(EALTH#ARE    0EACE+!

(304) /RME3-

(305) 4HOMPSON!2

(306) 0ADAYATTY3

(307) %LLIS!7

(308) "ELCHETZ0%#OGNITIVEDYSFUNCTION INPATIENTSTREATEDFORPITUITARYTUMOURS*#LIN%XP.EUROPSYCHOL    4REPP2

(309) %VERTS2

(310) 3TETTLER#ETAL!SSESSMENTOFQUALITYOFLIFEINPATIENTSWITHUNCONTROLLED VS CONTROLLED ACROMEGALY USING THE !CROMEGALY 1UALITY OF ,IFE 1UESTIONNAIRE !CRO1O,  #LIN%NDOCRINOL/XF     (INZ!

(311) +LAIBERG!

(312) 3CHUMACHER*

(313) "RAHLER%;4HEPSYCHOMETRICQUALITYOFTHE.OTTINGHAM (EALTH0ROlLE.(0 INTHEGENERALPOPULATION=0SYCHOTHER0SYCHOSOM-ED0SYCHOL   . .

(314) $IBQUFS .  3METS %-

(315) 6ISSER -2

(316) 7ILLEMS 'ROOT !&

(317) 'ARSSEN "

(318) 3CHUSTER 5ITTERHOEVE !,

(319) $E (AES *# &ATIGUE AND RADIOTHERAPY " EXPERIENCE IN PATIENTS  MONTHS FOLLOWING TREATMENT "R * #ANCER    3PINHOVEN0

(320) /RMEL*

(321) 3LOEKERS00

(322) +EMPEN')

(323) 3PECKENS!%

(324) VAN(EMERT!-!VALIDATION STUDY OF THE (OSPITAL !NXIETY AND $EPRESSION 3CALE (!$3 IN DIFFERENT GROUPS OF $UTCH SUBJECTS0SYCHOL-ED    6AN DER :EE +)

(325) 3ANDERMAN 2 (ET METEN VAN DE ALGEMENE GEZONDHEIDSTOESTAND MET DE 2!.$ 

(326) EENHANDLEIDING.OORDELIJK#ENTRUMVOOR'EZONDHEIDSVRAAGSTUKKEN

(327) 'RONINGEN

(328) 4HE.ETHERLANDS   6ANDER:EE+)

(329) 3ANDERMAN2

(330) (EYINK*!COMPARISONOFTWOMULTIDIMENSIONALMEASURESOF HEALTHSTATUSTHE.OTTINGHAM(EALTH0ROlLEANDTHE2!.$ )TEM(EALTH3URVEY1UAL ,IFE2ES    "ATES!3

(331) %VANS!*

(332) *ONES0

(333) #LAYTON2.!SSESSMENTOF'(STATUSINADULTSWITH'(DEl CIENCYUSINGSERUMGROWTHHORMONE

(334) SERUMINSULIN LIKEGROWTHFACTOR )ANDURINARYGROWTH HORMONEEXCRETION#LIN%NDOCRINOL/XF     (ARTMAN-,

(335) #ROWE"*

(336) "ILLER"-

(337) (O++

(338) #LEMMONS$2

(339) #HIPMAN**7HICHPATIENTSDO NOTREQUIREA'(STIMULATIONTESTFORTHEDIAGNOSISOFADULT'(DElCIENCY*#LIN%NDOCRINOL -ETAB    4OOGOOD!!

(340) "EARDWELL#'

(341) 3HALET3-4HESEVERITYOFGROWTHHORMONEDElCIENCYINADULTS WITHPITUITARYDISEASEISRELATEDTOTHEDEGREEOFHYPOPITUITARISM#LIN%NDOCRINOL/XF      :IGMOND!3

(342) 3NAITH204HEHOSPITALANXIETYANDDEPRESSIONSCALE!CTA0SYCHIATR3CAND     3METS%-

(343) 'ARSSEN"

(344) "ONKE"

(345) $E(AES*#4HE-ULTIDIMENSIONAL&ATIGUE)NVENTORY-&) PSYCHOMETRICQUALITIESOFANINSTRUMENTTOASSESSFATIGUE*0SYCHOSOM2ES    (UNT3-

(346) -C+ENNA30

(347) -C%WEN*

(348) "ACKETT%-

(349) 7ILLIAMS*

(350) 0APP%!QUANTITATIVEAPPROACHTO PERCEIVEDHEALTHSTATUSAVALIDATIONSTUDY*%PIDEMIOL#OMMUNITY(EALTH    (UNT 3-

(351) -C%WEN * 4HE DEVELOPMENT OF A SUBJECTIVE HEALTH INDICATOR 3OCIOL (EALTH )LLN     "RAZIER*%

(352) (ARPER2

(353) *ONES.-ETAL6ALIDATINGTHE3& HEALTHSURVEYQUESTIONNAIRENEW OUTCOMEMEASUREFORPRIMARYCARE"-*    7ARE*%

(354) *R

(355) 3HERBOURNE#$4HE-/3 ITEMSHORT FORMHEALTHSURVEY3&  )#ONCEP TUALFRAMEWORKANDITEMSELECTION-ED#ARE    'RIMES$!

(356) 3CHULZ+&#OMPAREDWITHWHAT&INDINGCONTROLSFORCASE CONTROLSTUDIES,ANCET     7ACHOLDER3

(357) 3ILVERMAN$4

(358) -C,AUGHLIN*+

(359) -ANDEL*33ELECTIONOFCONTROLSINCASE CONTROL STUDIES))4YPESOFCONTROLS!M*%PIDEMIOL    0EACE+!

(360) /RME3-

(361) 3EBASTIAN*0ETAL4HEEFFECTOFTREATMENTVARIABLESONMOODANDSOCIAL ADJUSTMENT IN ADULT PATIENTS WITH PITUITARY DISEASE #LIN %NDOCRINOL /XF      0EACE+!

(362) /RME3-

(363) 0ADAYATTY3*

(364) 'ODFREY(0

(365) "ELCHETZ0%#OGNITIVEDYSFUNCTIONINPATIENTS WITHPITUITARYTUMOURWHOHAVEBEENTREATEDWITHTRANSFRONTALORTRANSSPHENOIDALSURGERYOR MEDICATION#LIN%NDOCRINOL/XF     -INDERMANN4

(366) 7ILSON#"!GE RELATEDANDGENDER RELATEDOCCURRENCEOFPITUITARYADENOMAS #LIN%NDOCRINOL/XF     +ORALI:

(367) 7ITTCHEN(5

(368) 0lSTER(

(369) (OmER-

(370) /EFELEIN7

(371) 3TALLA'+!REPATIENTSWITHPITUITARY ADENOMASATANINCREASEDRISKOFMENTALDISORDERS!CTA0SYCHIATR3CAND  .

(372) 2VBMJUZPGMJGFJTEFDSFBTFEJOQBUJFOUTUSFBUFEGPSOPOGVODUJPOJOHQJUVJUBSZNBDSPBEFOPNB.  $EKKERS/-

(373) 0EREIRA!-

(374) 2OELFSEMA&ETAL/BSERVATIONALONEAFTERTRANSSPHENOIDALSURGERY FORNONFUNCTIONINGPITUITARYMACROADENOMA*#LIN%NDOCRINOL-ETAB  2OMIJN*!

(375) 3MIT*7

(376) ,AMBERTS37)NTRINSICIMPERFECTIONSOFENDOCRINEREPLACEMENTTHERAPY %UR*%NDOCRINOL    VAN4HIEL37

(377) 2OMIJN*!

(378) 0EREIRA!-ETAL%FFECTSOFDEHYDROEPIANDROSTENEDIONE

(379) SUPERIM POSEDONGROWTHHORMONESUBSTITUTION

(380) ONQUALITYOFLIFEANDINSULIN LIKEGROWTHFACTOR)IN PATIENTSWITHSECONDARYADRENALINSUFlCIENCYARANDOMIZED

(381) PLACEBO CONTROLLED

(382) CROSS OVER TRIAL*#LIN%NDOCRINOL-ETAB    -AINIO!

(383) (AKKO(

(384) .IEMELA!

(385) +OIVUKANGAS*

(386) 2ASANEN0'ENDERDIFFERENCEINRELATIONTO DEPRESSION AND QUALITY OF LIFE AMONG PATIENTS WITH A PRIMARY BRAIN TUMOR %UR 0SYCHIATRY   !GEWALL 3

(387) "ERGLUND -

(388) (ENAREH , 2EDUCED QUALITY OF LIFE AFTER MYOCARDIAL INFARCTION IN WOMENCOMPAREDWITHMEN#LIN#ARDIOL    "ERNKLEV4

(389) *AHNSEN*

(390) !ADLAND%ETAL(EALTH RELATEDQUALITYOFLIFEINPATIENTSWITHINmAM MATORYBOWELDISEASElVEYRAFTERTHEINITIALDIAGNOSIS3CAND*'ASTROENTEROL    -YSTAKIDOU+

(391) 4SILIKA%

(392) 0ARPA%

(393) +ATSOUDA%

(394) 'ALANOS!

(395) 6LAHOS,!SSESSMENTOF!NXIETY AND$EPRESSIONIN!DVANCED#ANCER0ATIENTSANDTHEIR2ELATIONSHIPWITH1UALITYOF,IFE1UAL ,IFE2ES    .ORRIS #-

(396) 'HALI 7!

(397) 'ALBRAITH 0$

(398) 'RAHAM --

(399) *ENSEN ,!

(400) +NUDTSON -, 7OMEN WITH CORONARYARTERYDISEASEREPORTWORSEHEALTH RELATEDQUALITYOFLIFEOUTCOMESCOMPAREDWITH MEN(EALTH1UAL,IFE/UTCOMES  !RWERT,)

(401) $EIJEN*"

(402) 7ITLOX*

(403) $RENT-,4HEINmUENCEOFGROWTHHORMONE'( SUBSTITUTION ONPATIENT REPORTEDOUTCOMESANDCOGNITIVEFUNCTIONSIN'(DElCIENTPATIENTSAMETA ANALY SIS'ROWTH(ORM)'&2ES    "LUM7&

(404) 3HAVRIKOVA%0

(405) %DWARDS$*ETAL$ECREASEDQUALITYOFLIFEINADULTPATIENTSWITH GROWTH HORMONE DElCIENCY COMPARED WITH GENERAL POPULATIONS USING THE NEW

(406) VALIDATED

(407) SELF WEIGHTED QUESTIONNAIRE

(408) QUESTIONS ON LIFE SATISFACTION HYPOPITUITARISM MODULE * #LIN %NDOCRINOL-ETAB    $EIJEN*"

(409) !RWERT,)

(410) 7ITLOX*

(411) $RENT-,$IFFERENTIALEFFECTSIZESOFGROWTHHORMONEREPLACE MENTON1UALITYOF,IFE

(412) WELL BEINGANDHEALTHSTATUSINGROWTHHORMONEDElCIENTPATIENTSA META ANALYSIS(EALTH1UAL,IFE/UTCOMES  'IBNEY*

(413) 7ALLACE*$

(414) 3PINKS4ETAL4HEEFFECTSOFYROFRECOMBINANTHUMANGROWTHHOR MONE'( INADULT'(DElCIENTPATIENTS*#LIN%NDOCRINOL-ETAB    3TOUTHART 0*

(415) $EIJEN *"

(416) 2OFFEL -

(417) $ELEMARRE VAN DE 7AAL (! 1UALITY OF LIFE OF GROWTH HORMONE '( DElCIENT YOUNG ADULTS DURING DISCONTINUATION AND RESTART OF '( THERAPY 0SYCHONEUROENDOCRINOLOGY    3ONKSEN 0(

(418) -C'AULEY ' ,IES

(419) DAMN LIES AND STATISTICS 'ROWTH (ORM )'& 2ES    . .

(420)

(421)

Referenties

GERELATEERDE DOCUMENTEN

In adult women with growth hormone defi ciency (GHD) on a stable rhGH replacement dose, IGF-I levels increased during a switch from oral to transdermal 17β-estradiol therapy, however,

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

Patients cured from craniopharyngioma or non-functioning pituitary macroadenoma suff er similarly from increased daytime somnolence despite normal sleep patterns compared to

Circadian variations in melatonin secretion are under the control of endogenous clock signals arising from the suprachiasmatic nucleus (SCN) of the hypothalamus. We hypothesized that

(FOFSBMEJTDVTTJPOBOETVNNBSZ  %FUFSNJOBOUTBOEQSFEJDUPSTPGUVNPSSFDVSSFODFBGUFSTVSHJDBMUSFBUNFOU 4HE KNOWN SURGERY OF DIOTHERAPY TOCHEMISTRY PREDICTORS )T

%JTDVTTJFFOTBNFOWBUUJOH  %FSPMWBOQPTUPQFSBUJFWFSBEJPUIFSBQJF /VER NOG TERMIJN CHIRURGIE RECIDIEF  RADIOTHERAPIE RADIOTHERAPIE TERMIJN RADIOTHERAPIE (ET

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded from: https://hdl.handle.net/1887/4975.

Er is geen indicatie om alle patiënten met een tumorrest na operatie voor een niet-functione- rend hypofyse macroadenoom routinematig te bestralen..